- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CSTA antibody targets Cystatin A, a cytoplasmic cysteine protease inhibitor encoded by the CSTA gene and a member of the type I cystatin family. Cystatin A is also commonly referred to as Stefin A and functions primarily as an endogenous inhibitor of lysosomal cysteine proteases such as cathepsins B, H, and L. Through this inhibitory activity, Cystatin A plays an important role in protecting cells from inappropriate protease-mediated protein degradation and maintaining epithelial barrier integrity.
Cystatin A is predominantly localized in the cytoplasm and is highly expressed in stratified squamous epithelia, including epidermis, oral mucosa, and esophagus. It is also detectable in epithelial-derived tumors and certain immune cell populations. Within epithelial cells, Cystatin A contributes to terminal differentiation processes and helps regulate protease activity during keratinization. CSTA antibody detection is therefore useful for studying epithelial differentiation, protease regulation, and tissue homeostasis.
Functionally, Cystatin A acts as a tight-binding inhibitor of papain-like cysteine proteases, limiting their proteolytic activity under physiological conditions. By modulating cathepsin activity, Cystatin A influences processes such as cell migration, apoptosis, and inflammatory responses. Its role in balancing protease activity makes CSTA antibody reagents valuable tools for investigating protease-inhibitor networks in normal tissues and disease models.
Altered expression of Cystatin A has been reported in a variety of pathological contexts, particularly in epithelial malignancies. Reduced or aberrant CSTA expression has been associated with tumor invasion and progression, while increased expression is often observed in well-differentiated squamous cell carcinomas. In addition, changes in Cystatin A levels have been linked to inflammatory skin disorders and barrier dysfunction. These associations underscore the relevance of CSTA antibody-based detection in cancer biology and epithelial pathology research.
Clone MSVA-461M is designed to recognize Cystatin A in research applications. CSTA antibody reagents are suitable for detecting protein expression and localization in epithelial tissues and tumor samples, supporting studies focused on protease regulation, epithelial differentiation, and disease-associated changes in cysteine protease inhibition.
1. Optimal dilution of the CSTA/Cystatin A antibody should be determined by the researcher.
2. This CSTA/Cystatin A antibody is recombinantly produced by expression in CHO cells.
3. Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121oC in pH 7.8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37oC for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
Recombinant full-length human CSTA protein was used as the immuongen for the CSTA/Cystatin A antibody.
CSTA/Cystatin A antibody with sodium azide - store at 2 to 8oC; antibody without sodium azide - store at -20 to -80oC.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.